Marathon-Induced Cardiac Strain as Model for the Evaluation of Diagnostic microRNAs for Acute Myocardial Infarction.
biomarker
exercise
marathon running
microRNAs
myocardial infarction
troponin
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
21 Dec 2021
21 Dec 2021
Historique:
received:
21
11
2021
revised:
16
12
2021
accepted:
17
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
12
1
2022
Statut:
epublish
Résumé
The current gold standard biomarker for myocardial infarction (MI), cardiac troponin (cTn), is recognized for its high sensitivity and organ specificity; however, it lacks diagnostic specificity. Numerous studies have introduced circulating microRNAs as potential biomarkers for MI. This study investigates the MI-specificity of these serum microRNAs by investigating myocardial stress/injury due to strenuous exercise. MicroRNA biomarkers were retrieved by comprehensive review of 109 publications on diagnostic serum microRNAs for MI. MicroRNA levels were first measured by next-generation sequencing in pooled sera from runners ( 27 potential diagnostic microRNA for MI were retrieved by the literature review. Eight microRNAs (miR-1-3p, miR-21-5p, miR-26a-5p, miR-122-5p, miR-133a-3p, miR-142-5p, miR-191-5p, miR-486-3p) showed positive correlations with cTnT in marathon runners, whereas two miRNAs (miR-134-5p and miR-499a-5p) showed no correlations. Upregulation of miR-133a-3p ( Some MI-associated microRNAs (e.g., miR-133a-3p and miR-142-5p) have similar kinetics under strenuous exercise and MI as compared to cTnT, which suggests that their diagnostic specificity could be limited. In contrast, several MI-associated microRNAs (miR-26a-5p, miR-134-5p, miR-191-5p) showed different release behavior; hence, combining cTnT with these microRNAs within a multi-marker strategy may add diagnostic accuracy in MI.
Sections du résumé
BACKGROUND
BACKGROUND
The current gold standard biomarker for myocardial infarction (MI), cardiac troponin (cTn), is recognized for its high sensitivity and organ specificity; however, it lacks diagnostic specificity. Numerous studies have introduced circulating microRNAs as potential biomarkers for MI. This study investigates the MI-specificity of these serum microRNAs by investigating myocardial stress/injury due to strenuous exercise.
METHODS
METHODS
MicroRNA biomarkers were retrieved by comprehensive review of 109 publications on diagnostic serum microRNAs for MI. MicroRNA levels were first measured by next-generation sequencing in pooled sera from runners (
RESULTS
RESULTS
27 potential diagnostic microRNA for MI were retrieved by the literature review. Eight microRNAs (miR-1-3p, miR-21-5p, miR-26a-5p, miR-122-5p, miR-133a-3p, miR-142-5p, miR-191-5p, miR-486-3p) showed positive correlations with cTnT in marathon runners, whereas two miRNAs (miR-134-5p and miR-499a-5p) showed no correlations. Upregulation of miR-133a-3p (
CONCLUSION
CONCLUSIONS
Some MI-associated microRNAs (e.g., miR-133a-3p and miR-142-5p) have similar kinetics under strenuous exercise and MI as compared to cTnT, which suggests that their diagnostic specificity could be limited. In contrast, several MI-associated microRNAs (miR-26a-5p, miR-134-5p, miR-191-5p) showed different release behavior; hence, combining cTnT with these microRNAs within a multi-marker strategy may add diagnostic accuracy in MI.
Identifiants
pubmed: 35011745
pii: jcm11010005
doi: 10.3390/jcm11010005
pmc: PMC8745173
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Bratisl Lek Listy. 2018;119(6):341-347
pubmed: 29947233
Clin Lab. 2020 Jun 1;66(6):
pubmed: 32538053
J Am Coll Cardiol. 2014 Jun 10;63(22):2411-20
pubmed: 24747102
BMC Med Genomics. 2013 May 04;6:16
pubmed: 23641832
Biomarkers. 2020 Nov;25(7):539-547
pubmed: 32723190
Cardiovasc Diagn Ther. 2020 Jun;10(3):421-430
pubmed: 32695622
Clinics (Sao Paulo). 2019 Nov 07;74:e1237
pubmed: 31721935
Med Sci Monit. 2019 May 27;25:3925-3932
pubmed: 31130720
Clin Sci (Lond). 2010 Apr 20;119(2):87-95
pubmed: 20218970
Trends Cardiovasc Med. 2017 Jul;27(5):326-333
pubmed: 28256378
Rev Port Cardiol. 2005 Jun;24(6):819-31
pubmed: 16121674
Sci Rep. 2020 Mar 25;10(1):5373
pubmed: 32214121
EMBO Mol Med. 2012 Nov;4(11):1176-85
pubmed: 23023917
Ann Transl Med. 2016 Dec;4(24):539
pubmed: 28149900
Am J Cardiol. 2002 Feb 15;89(4):484-6
pubmed: 11835940
Med Sci Sports Exerc. 2012 Jan;44(1):18-26
pubmed: 21659904
Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):9041-9045
pubmed: 32964994
Mol Med Rep. 2016 Sep;14(3):2867-75
pubmed: 27484208
Circulation. 2019 Sep 9;140(10):804-814
pubmed: 31401842
Minerva Cardioangiol. 2015 Oct;63(5):397-402
pubmed: 26198874
Nucleic Acids Res. 2017 Sep 6;45(15):8731-8744
pubmed: 28911107
Nucleic Acids Res. 2018 Jan 4;46(D1):D160-D167
pubmed: 29036653
Eur Heart J Acute Cardiovasc Care. 2021 Aug 24;10(6):653-660
pubmed: 33580779
Front Physiol. 2020 Jun 11;11:654
pubmed: 32595526
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264
pubmed: 30153967
Eur J Med Res. 2020 Mar 17;25(1):2
pubmed: 32178736
Am J Cardiol. 2004 Sep 1;94(5):696-8
pubmed: 15342317
Br J Anaesth. 2020 Nov;125(5):661-671
pubmed: 32718726
PLoS One. 2016 Feb 09;11(2):e0148599
pubmed: 26859843
IUBMB Life. 2020 Mar;72(3):384-400
pubmed: 31675148
Ir J Med Sci. 2020 Aug;189(3):933-937
pubmed: 32064546
Arq Bras Cardiol. 2015 Jul;105(1):53-64
pubmed: 25993485
Trends Cell Biol. 2012 Mar;22(3):125-32
pubmed: 22260888
Mol Med Rep. 2016 Jul;14(1):184-94
pubmed: 27176713
Med Sci Sports Exerc. 2011 Oct;43(10):1819-27
pubmed: 21448080
IUBMB Life. 2020 Nov;72(11):2499-2507
pubmed: 32916037
Nat Rev Immunol. 2010 Feb;10(2):111-22
pubmed: 20098459
Braz J Med Biol Res. 2020 Jan 24;53(2):e9106
pubmed: 31994603
J Appl Physiol. 1974 Aug;37(2):247-8
pubmed: 4850854
Bratisl Lek Listy. 2017;118(11):684-690
pubmed: 29216725
Clin Chem. 2011 Oct;57(10):1452-5
pubmed: 21807867
J Clin Med. 2020 May 11;9(5):
pubmed: 32403263
Life Sci. 2019 Sep 1;232:116547
pubmed: 31176780
Kardiol Pol. 2008 Mar;66(3):253-9, discussion 260-1
pubmed: 18393112
Biomed Res Int. 2014;2014:418628
pubmed: 24900964
Circ Cardiovasc Genet. 2010 Dec;3(6):499-506
pubmed: 20921333
Am Heart J. 2002 May;143(5):814-20
pubmed: 12040342
Can J Cardiol. 2021 Jan;37(1):77-85
pubmed: 32735867
Diagn Pathol. 2020 Mar 3;15(1):19
pubmed: 32127011
Heart. 2016 Aug 15;102(16):1270-8
pubmed: 26955848
Avicenna J Med Biotechnol. 2010 Oct;2(4):161-79
pubmed: 23407304
J Am Coll Cardiol. 2001 Jan;37(1):153-6
pubmed: 11153730
Diagnostics (Basel). 2020 Oct 13;10(10):
pubmed: 33066215
Respir Res. 2010 Nov 23;11:159
pubmed: 21092244
BMC Cardiovasc Disord. 2017 Aug 22;17(1):227
pubmed: 28830367
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
IUBMB Life. 2016 Aug;68(8):673-82
pubmed: 27346801
J Mol Cell Cardiol. 2021 Feb;151:155-162
pubmed: 32305360
Pak J Med Sci. 2013 Jul;29(4):1003-7
pubmed: 24353676
J Interv Cardiol. 2010 Oct;23(5):443-50
pubmed: 20663014
J Pharm Anal. 2019 Aug;9(4):217-226
pubmed: 31452959
Nucleic Acids Res. 2020 Jan 8;48(D1):D142-D147
pubmed: 31691816
Int J Environ Res Public Health. 2015 Oct 30;12(11):13981-4020
pubmed: 26529003
Int J Cardiol Heart Vasc. 2019 Mar 14;22:181-186
pubmed: 30963092
Basic Res Cardiol. 2011 Jan;106(1):13-23
pubmed: 20886220
Indian Pacing Electrophysiol J. 2008 Aug 01;8(3):172-4
pubmed: 18679521
Nat Rev Genet. 2015 Jul;16(7):421-33
pubmed: 26077373
Science. 2005 Sep 2;309(5740):1573-6
pubmed: 16081698
Biomark Med. 2013 Aug;7(4):623-31
pubmed: 23905899
Eur Heart J. 2010 Sep;31(18):2197-204
pubmed: 20685679